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Summary
We had previously obtained evidence that among normal subjects the humoral antibody response
to hepatitis B surface antigen (HBsAg) was bimodally distributed with about 14% of subjects
producing <1,000 estimated radioimmunoassay RIA units . From the study of major histo-
compatibility complex(MHC) markers in the very poor responders who produced <36 estimated
RIA units of antibody, it appeared that there was an excess of homozygotes for two extended
haplotypes [HLAB8, SC01, DR3] and [HLA-B44, FC31, DR7] . This finding suggested that
a poor response was inherited as a recessive trait requiring nonresponse genes for HBsAg on
bothMHC haplotypes and was strengthened by finding a much lower antibody response among
prospectively immunized homozygotes for [HLAB8, SCOT, DR3] compared with heterozygotes .
In the present study, we have analyzed the cellular basis for nonresponse to this antigen by examining
antigen-specific proliferation of T cells from responders and nonresponders in the presence and
absence of autologous CD8+ (suppressor) cells .
Peripheral blood cells from nonresponders to HB&Ag failed to undergo a proliferative response
to recombinant HB&Ag in vitro, whereas cells from responders proliferated vigorously. This failure
of cells from nonresponders to proliferate was not reversed in cell mixtures containing CD4+
and antigen-presenting cells devoid ofCD8+ cells . There was no difference between responders
and nonresponders with respect to the number of circulating T cells or their subsets, or the
proliferative response to mitogens such as pokeweed or phytohemagglutinin or another antigen,
tetanus toxoid.
Our results indicate that our HBsAg nonresponding subjects have a very specific failure in
antigen presentation or the stimulation ofT helper cells, or both . Our evidence is against specific
immune suppression as the basis for their nonresponsiveness. The failure of antigen presentation
or T cell help is consistent with recessive inheritance of nonresponsiveness and suggests that
response is dominantly inherited .
T
he humoral antibody response to protein antigens is con-
trolled by class IIMHC genes in the mouse and other
mammalian species (1, 2) . Although antibody responses to
synthetic peptides are controlled byMHC genes in mice, ex-
periments to show this in humans are less conclusive (3-5)
and the presence or absence of response has not been associated
with any specificHLA haplotype. Other studies in vitro using
human cells have provided evidence forMHC immune sup-
pression genes to collagen (6), cryptomeriajaponica pollen (7),
schistosomal antigen (Sj)t (8), and streptococcal cell wall
'Abbreviations used in this paper HB, hepatitis B ; HB&Ag, hepatitis B
surface antigen; ML, ncobacterium leprae antigen ; NBCS, newborn calf
serum; SCW, streptococcal cell wall antigen; Sj, schistosomal antigen .
(SCW) antigen (9), but comparable animal models have not
been found.
The hepatitisB surface antigen is the first protein associated
with MHC-linked immune response in both mouse and
humans . In the mouse, the antibody response to HBsAg has
beenshown to beMHC controlled, with certain strains being
nonresponders, others mounting an intermediate response,
and still other strains a high response (10-14). In general,
response is inherited as a dominant trait and failure to re-
spond is inherited as a recessive trait . Studies of the failure
to respond to HBsAgamong normalJapanese have suggested
a high nonresponse rate of>20% and dominant inheritance
of the nonresponsiveness marked by the common Japanese
MHC haplotype HLABw54, DR4, DRw53 (15) . Consistent
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absence of response couldbe attributed to suppression, since,
in their study, removal of CD8+ cells from nonresponder
peripheral blood cells in vitro resulted in proliferativeresponse
and antibody production on exposure to HBsAg (15) .
In our previous studies, we have noted an increase among
Caucasian nonresponders (antibody levels of<36 estimated
RIAU/ml)ofHLADR3 andDR7 andtheextended haplo-
types [HLA-B8, SCO1, DR3] and [HLAB44, FC31, DR7],
and an overrepresentation of homozygotes for the latter two
haplotypes (16) . This suggested that nonresponsiveness was
a recessive trait and, by inference, that the specific immune
response to HBsAg is dominantly determined. Such a model
does not support a role for T cell suppression . An analysis
of the antibody response ofN600 normal Caucasian subjects
was consistent with at least two different populations. The
more poorly responding population comprised vl4% of the
total (17) . To test whether [HLAB8, SCOT, DR3] marked
a recessively expressed nonresponse gene for HBsAg, we
prospectively immunized homozygotesand heterozygotes for
the haplotype. The homozygotes were, in general, non- or
hyporesponders and had significantly lower antibody levels
than the heterozygotes (17) . In thepresent study, we analyze
the cellular mechanism of nonresponse to HBsAg, particu-
larly with respect to a possible role for immune suppression .
Materials and Methods
Subjects.
￿
Normal healthyCaucasian volunteerswho had previ-
ously received a full course of intramuscular (deltoid) immuniza-
tion with Heptavax-B (Merck Institute for Therapeutic Research,
West Point, PA) were studied . Three subjects were responders and
had mean antibody levels >2,000 estimated RIA U/ml as deter-
minedbyRIA (AUSAB ; Abbott Laboratories, North Chicago, IL)
whereas four were nonresponders andhad antibody levels <36 es-
timated RIA U/ml 8 wk after the last injection of vaccine . All
subjects were <40 yr-of-age and in good health ; all were typed
forHLA-A, B. C, DR, BF,C2, C4A, andC4Bby standard methods
(18, 19) . For the nonresponders, MHC haplotypes were known
from family studies ; in other cases, only phenotypes wereknown.
The HLA types of the four nonresponders and three responders
who served as subjects for the current study are given in Table 1.
Table 1.
￿
HLA Types of Nonresponders and Responders to Hepatitis B Vaccine
Individuals"
￿
HLA types
Nonresponders"
Responders
Three of four nonresponders were genotyped (italics), all other subjects were phenotyped .
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Each subject received a single intramuscular booster injection of
tetanus toxoid (Massachusetts Public Health Laboratories,Jamaica
Plain, MA) and a booster injection of 10 wg ofrecombinant hepa-
titis Bvaccine (Recombivax-HB; kindly supplied by Merck, Sharp
and Dohme, West Point, PA) . 4-6-weeks later, 450 ml of whole
blood was collected in CPD-A1 (Baxter-Travenol, Chicago, IL) .
Other individualswhohad never received hepatitis B vaccine nor
hada history ofhepatitis also donatedwholeblood for use in these
experiments.
Antigens andLectins.
￿
Recombinant HBsAg free of preservative
was a gift from RolandW . Ellis (Merck Institute for Therapeutic
Research). Tetanus toxoid was supplied by the Massachusetts Public
Health Laboratories. PHAwas obtained from Wellcome Research
Laboratories (Beckenham, UK) and PWM was purchased from
Sigma Chemical Co. (St . Louis, MO).
Cell Preparations .
￿
Fresh whiteblood cells were obtained from
heparin-anticoagulated venous blood by centrifugation and were
furtherpurified by Ficoll-Hypaque (Pharmacia FineChemicals, Pis-
cataway, NJ) density gradient centrifugation . Cells were cultured
in RPMI 1640 supplemented with 10% FCS, 2 mmol/liter of
r.-glutamine, 50U/m1 ofpenicillin, and50 lAg/ml of streptomycin .
Fresh cells were used in all kinetic and reconstitution experiments .
Immunofluorescence anddose-response experiments were carried
out with thawed frozen cells.
IsolationandEnrichment ofTCell Subsets.
￿
T cells were enriched
by E-rosetting (20) . CD4* T cells and CD8+ T cells were en-
riched by a panning method as described earlier (21-23) and were
cultured in media with newborn calf serum (NBCS) .
Isolation ofAdherent Cells.
￿
Monocytes were collected from ad-
herent fractions and were >96% Mo-1* and<3% CD3', as de-
termined by FACS® (Becton Dickinson&Co., Mountain View,
CA) analysis (24) . Indirect immunofluorescence on 106 cells was
done using anti-CD3, anti-CD4, andanti-CD8 from Becton Dick-
inson and Co. (Mountain View, CA) and FITC-conjugated goat
anti-Fab antibody (25) . Cells were analyzed on an Epic 750 Series
cell sorter (Coulter Electronics Inc., Hialeah, FL) coupled with
an Innova 90 5-Wargon laser (Coherent Inc., Palo Alto, CA). Di-
rect immunofluorescence was analyzed with PE-conjugated anti-
CD29 (4B4)andanti-CD45R (2H4) antibodies (Coulter Electronics
Inc.) . The proportion of different cells was given as percent (26) .
Antigen-Specifc T Cell Proh&ahon .
￿
Unfractionated PBL (106/ml)
were incubatedwith different concentrations ofHB&Ag (0.01, 0.05,
0.1, 0.2, 0.5, 1, 10, and 20 wg/ml) . Tetanus toxoid at 10 ug/ml
andPHA andPWM at0.5 jig/ml were used as controls. ['H]Thy-
midine incorporation was measured after 3, 5, 7, and9din culture.
1 A2, A28, Cw2, B44, BX, SC31, SC33, DR2, DRX, DQwl, DQwX
2 A1, B8, SC01, DR3, DQw2/Al, Cw3, Bw60, SB42, DR4, DQw3
3 A1, B8, SC01, DR3, DQw2/A1, B18, SC01, DR3, DQw2
4 A1, B8, SC01, DR3, DQw2/Ai, B8, SC01, DR3, DQw2
1 A25, A32, B44, B21, Cw5, SFC31, DRw12, DR7, DQw2, DQw3
2 Al, A23, B7, B38, Cw7, SC31, DR2, DR4, DQwl, DQw3
3 Al, A2, B44, Bw60, Cw3, SFC31, DR7, DQw2Because of the well-known variability in background [3H]thy-
midine incorporation from experiment to experiment andfrom in-
dividual to individual, a stimulation index (SI) was calculated for
each mitogen for each set of experiments . The SI is the ratio of
experimental to background net counts per minute . Background
and specific antigen and mitogen experiments were always done
simultaneously for any one subject, although, in general, at least
one responder and one nonresponder were studied together.
Reconstitution Experiments.
￿
The three fractionated cell popula-
tions, obtained as described, were mixed (0.5 x 10 6/CD4* T
cells, 0.5 x 106 CD8* T cells, and 2 x 10° monocytes in NBCS
medium) and cultured . For the definitive experiments, concentra-
tion of HBsAg was 0.2 ug/ml and [3H]thymidine incorporation
was measured up to day 7 in culture.
Statistical Analysis.
￿
All cultures were done in triplicate and the
proliferation data were determined as the arithmetic means. Results
were expressed as the difference in the cpm of the stimulated and
unstimulated cultures +/- SEM, as A of cpm t SEM ofcpm
or as the mean ± one SD and converted to SI, as above .
Results
Proliferation in the Presence ofHBsAg .
￿
The optimal dose
ofHBsAg for proliferation experiments was determined using
cells from responders. Onesuch experiment is shown in Fig.
1 where the optimal HBsAg concentration was 0.2 Ag/ml.
Higher concentrations elicited less proliferationandno prolifer-
ation was observed at concentrations of HBsAg of 1 Ag/ml
or higher. Cells from four nonvaccinated healthy controls or
from the three vaccinated butnonresponding individuals did
not show proliferation under any conditions tested .
Kinetics o,fProliferative Responses to HBsAg, Tetanus Toxoid,
and Lectins (PHA and PWAI) . These experiments, shown
in Table 2 andFig. 2, were performed on freshly isolated lym-
phocytes from three responders and three nonresponders. As
expected, cells from both the responders and nonresponders
showed significant proliferation on exposure to tetanus toxoid,
PHA, and PWM. Fig. 2 displays the peak proliferative re-
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Figure 1.
￿
Proliferative response to different concentrations of HBsAg .
Data are expressed as cpm t SE . 105 PBL were incubated in different
concentrations of HBsAg in a final volume of 200 pl in triplicate. After
6 d of incubation, 0.8 F&Ci of [3H]Tdr in 20 pl was added to each culture
and kept overnight (18 h) . (") One responder; (O) one nonresponder;
(0) a nonvaccinated individual .
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Figure 2 .
￿
Kinetics of proliferative responses to HBsAg. Data are ex-
pressed as mean of,& cpm ± SEM ofthe cpm. PBL were incubated with
0 .2 Pg/ml of HBsAg and the cultures harvested at 3, 5, 7, and 9 d . (A)
The results of three responders to hepatitis B vaccine ; and (B) the results
of three nonresponders to hepatitis B vaccine.
sponse to HBsAg, PHA, andPWM in each subject . Although
there was considerable variability in the proliferative response
to this antigen and these mitogens, there was no pattern and
no correlation with proliferation in response to HBsAg in
the same subjects. The optimal response to tetanus toxoid
was between days 5 and 7, whereas the greatest responses
to PHA andPWM occurred on days 3 and 5 . The responses
to PHA and PWM were significant even on day 7 . These
results contrasted with the proliferative response to HBsAg,
in which responders showed peak proliferation on day 7,
ranging from 39,000 to 57,000 cpm (Fig . 2"A) . Maximum
values for nonresponders fell between -130 and 210, not
Table 3 .
￿
Antibody Response and Prolferative Response ofCD4' T Lymphocytes to HBsAg
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different from control cultures without HBsAg when the
SEM ofA cpm was taken into account (Fig. 2 B) . The lack
of specific proliferative response toHBsAg by cells from non-
responders is evident over the entire 9-d period of observation .
Absence of Specific T Cell Proliferation to HBsAg in Non-
responders is not Mediated by CD8+ Cells. Enriched CD4+
cells (85-95% pure) and monocytes (96% pure) were cocul-
tured with and without HBsAg (0.2 hg/ml) for 7 d . The
results are shown in Table 3 . For all responders, culturing
reconstituted monocytes with CD4+ cells and antigen
resulted in significant proliferation (from 3,170 to 42,570 cpm,
or 3.3 to 18.8 times greater than background). Cells from
nonresponders, including one subject tested twice, showed
proliferation values in response toHBsAg comparable to back-
ground cultures (0.89-1.34 times background) . Thus, removal
of CD8+ cells did not change the lack of proliferative re-
sponse to HBsAg by cells from nonresponders.
Reconstitution experiments were also performed using
tetanus toxoid and PHA as control antigens. Table 4 shows
the results ofthese experiments. PHA (not shown) and tetanus
toxoid produced significant proliferation in cells from both
responders and nonresponders. Reconstituted monocytes and
CD4+ cells, depleted of CD8+ cells, from nonresponders
failed to proliferate in response to HBsAg in all instances.
The addition ofCD8+ cells (58-69% pure) to the above cell
mixtures resulted in decreased proliferative responses to tetanus
toxoid in six of seven individuals. With PHA (results not
shown) this phenomenon was evident in only three of seven
subjects . Addition ofCD8+ cells to cultures with HBsAg
produced even lower values in one of three responders and
in four of four nonresponders ; and in three of five experi-
ments in nonresponders, proliferation was below the back-
ground level, indicating that the CD8+ cells had suppressor
function (Table 4) .
Antibody levels as RIA U/ml were measured in serum obtained either before or 4-6wk after a booster .challenge with recombinant HBsAg vaccine .
t The cells used in these studies were obtained 8 wk after a full vaccination course with recombinant HBsAg vaccine .
s Data expressed as mean cpm of triplicate cultures ± SD .
II SI = mean cpm in cultures of cells with HBsAg/mean cpm in cultures of cells without HBsAg .
1 This subject was considered a nonresponder based on an antibody level of <36 RIA U/ml after a standard course of three injections .
Individuals
Antibody
Pre-booster
response'
Post-booster
HBsAg Added to Monocytes
and CD4* T cellllt
Nones 0.2 Wg/mls SO
Nonresponders 1 32 2,9911 1,491 ± 140 1,334 ± 139 0.9
2 8 20 6,576 ± 2,116 7,366 ± 1,264 1 .1
3a <8 <8 2,455 ± 325 2,824 ± 642 1 .1
3b <8 <8 874 *- 644 1,174 ± 530 1.3
4 <8 <8 1,226 ± 172 1,235 ± 243 1 .0
Responders 1 456 59,840 1,554 ± 152 5,137 ± 495 3.3
2 8,068 86,300 2,268 ± 396 42,570 ± 2,835 18.8
3 52,267 244,480 205 ± 121 3,172 ± 911 15.50
.
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Numbers of Circulating CD4+ and CD8+ T Cells in Re-
sponders and Nonresponders to HBsAg. As can be seen from
Table 5, there was no difference in the numbers of total T
cells (CD3+), helper T cells (CD4 + ), or suppressor T cells
(CD8+) in nonresponders to HBsAg compared with
responders . There was similarly no difference in the numbers
of CD29 (4B4+) and CD45R (2H4+) subsets of CD4+
cells.
Discussion
The failure to mount a humoral immune response to a
defined antigen can occur by one or more of a number of
possible MHC-determined mechanisms. There can be a hole
in the T cell repertoire determined by specificMHC mole-
cules during thymic education ofT cells (1-5, 27-29) or there
can be a failure of class II molecules of theMHC to interact
with processed antigen with resultant failure to activate T
helper (CD4+) cells. Either of these mechanisms can be
looked upon as a failure in antigen presentation and would
be expected to be manifested only in those individuals in whom
there is a defect specified by both chromosomes. Thus, non-
responders would be homozygous for nonresponder MHC
genes and nonresponsiveness would be inherited as a reces-
sive trait. On the other hand, if the failure to respond is due
to the presence of antigen-specific suppressor (CD8+) cells,
this would be expected to require only one chromosome
specifying suppression, nonresponders would generally be het-
erozygotes for immune suppressor genes and nonresponse
would thus be inherited as a dominant trait .
All studies of the antibody response to a standard course
of immunization withHBsAg have demonstrated that from
4 to 10% of normal healthy subjects do not respond or
respond poorly (16, 30-34) . The exact percentage depends
to some extent upon the definition of non- or hyporesponse.
The bimodality of the antibody response of a large normal
population of Caucasians (17) is compatible with genetic het-
erogeneity in the determination of the immune response to
HBsAg. That the MHC is involved in at least one genetic
determinant was supported by the finding that HLADR7
(35), DR3, DR4, and DR7 (16, 17, 36), and the two ex-
tended haplotypes [HLAB8, SCOT, DR3] and [HLAB44,
FC31, DR7] (16, 17) were increased among the Caucasian
nonresponders . Since homozygotes for these alleles and haplo-
types appeared to be particularly frequent among the non-
responders, it appeared that the MHC was contributing as
a recessive trait (16) . This hypothesis was tested by the prospec-
tive immunization of homozygotes and heterozygotes for
[HLAB8SCOTDR3]The homozotes roduced si- , , . yg pg
nificantly less antibody than the heterozygotes (17), consis-
tent with there being a recessively inherited and expressed
nonresponse gene for HBsAg on [HLAB8, SCOT, DR3] .
In our current study, we were unable to establish a reproduc-
ible antibody synthesis assay system and therefore chose to
use proliferation as a reliable index of the secondary T cell
response. Our findings are in all respects different from those
ofWatanabe et al. (15)who found that the absence ofa prolifer-
ative response and antibody synthesis by peripheral blood cells
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￿
T Cell Subpopulation Proportions of Nonresponders and Responders to HBsAg
of nonresponders in vitro could be reversed by removal of
CD8+ cells . Watanabe et al . (15) also noted that many of
their nonresponding subjects carried the haplotype HLA-
Bw54, DR4,DRw53,common inJapanese, as heterozygotes.
After making some assumptions based on linkage disequili-
brium, these authors found that, by the Thomson-Bodmer
analysis (37), inheritance oftheMHC markers was most likely
dominant (15) . The marked differences in findings between
the Japanese studies and ours may derive from ethnic differ-
ences in the populations studied . This possibility is enhanced
by the observations of a second group in Japan who also found
a major role for suppressor cells in unresponsiveness toHBsAg
(38) . Another possible source of discrepancy is that our sub-
jects were immunized intramuscularly into the deltoid, the
route reported to produce optimal immunization (39), whereas
Watanabe et al . (15) subjects were vaccinated subcutaneously,
known to be suboptimal (40) .
There have been many elegant studies of the antibody and
T cell proliferative responses to HBsAg in inbred mice . Some
strains produce no detectable antibody as a result of homozy-
gosity for nonresponding H-2 haplotypes such as H-2{ or
H-2S (10-14) . Thus, in the mouse in general, nonresponsive-
ness to HBsAg is a recessive trait and response is dominant,
since the Fl offspring of responder x nonresponder crosses
are responders (10-14) . There is a role for suppressor cells
in the murine anti-HBs response, albeit not as an explana-
tion for nonresponse. In the low responder B10.BR strain,
depletion ofCD8+ (Lyt-1,2+) (suppressor) T cells increased
both the subtype and group specific anti-HBs responses . How-
ever, this depletion did not correct the T cell proliferative
defect characteristic of the strain. Predictably, T cell prolifer-
ation in the responder mice was mediated by antigen-pre-
senting cells, and HBsAg-specific T cell proliferation was
mapped to the I-A and I-E subregions of the mouse H-2 re-
gion . These studies identified the defect in the HBsAg non-
responders as being at the level of T cell-APC interaction
(10-14, 38) .
Mechanisms for the immune response to HBsAg or its
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The percentages of CD29 and CD45R subsets ofCD4* were obtained by immunofluorescence using specific rnAbs and the Epic 750 cell sorter
(Coulter Electronics Inc.) .
failure in humans are less clear. Small numbers of HBsAg-
specific T and B cells are present in vaccinated individuals
(41-44) . In one study, T helper clones specific for HBsAg
proliferated in vitroupon stimulation with the antigen (43) .
Moreover, antibodies specific for the antigen enhanced cell
proliferation, suggesting antibody regulation ofT cells specific
for the same antigen (44) . However, it could not be con-
cluded that the lack of response in nonresponders resulted
from the lack ofantibodies . In other reports, peripheral blood
cells from hyperimmunized individuals synthesized anti-HBs
in vitro, although there was no cell-mediated hypersensitivity
or T cell proliferative response to HBsAg (45, 46) . In an-
other study, nonresponders to HBsAg had significantly higher
absolute and relative numbers of CD2+ (T11+), CD57+
(HNK-1+), and CD8* (T8+) lymphocytes and increased
numbers of suppressor lymphocytes (47) . Cell coculture ex-
periments suggested that the early stage of nonresponsiveness
is mainly due to a defect in the B cell repertoire, while the
later stage is caused by HBsAg-specific suppressorT cells (48).
Responsiveness and nonresponsiveness to anumber of an-
tigens has been investigated by Sasazuki and coworkers. They
found that HLADR molecules restrict the interaction of
CD4 * helper T cells and APC in studies of the response to
SCW (9, 49-51), Sj (8), andMycobacterium lepmeantigen (ML)
(52) . In these studies, the addition ofanti-HLA-DR mAbs
completely abolished the immune response in vitro to these
antigens in immune subjects (9, 50, 51) . The same group
showed that responses to these antigens were recessive traits,
whereas nonresponsiveness was dominantly expressed and as-
sociated with different HLA antigens (15, 50-53) . The re-
sponse to SCW was in association with HLA-DR2, DR5,
andDQwl, the response to Si with HLADw12, and toML
withHLAB35, Dw2 (50, 51, 53) . The IgE response to cedar
pollen was found to be negatively associated with HLA-
DQw3 . The lack of response to the hepatitis B vaccine was
found to be mediated by CD8+ cells inHLADQw4 posi-
tive individuals (15, 49, 51, 53, 54) .
Only further work will resolve the differences reported
Individuals CD3 *
Percent
CD4*
of Total Lymphocytes
CD8* CD4*/CD8*
Percent
CD29
(4114*)
of CD4* T Cells*
CD45R
(2H4*)
Nonresponders 1 66 38 24 1.58 46 46
2 79 44 29 1 .51 65 37
3 76 53 17 3 .11 65 37
4 ND 59 25 2 .36 59 50
Responders 1 70 49 23 2.13 55 44
2 62 46 10 4.60 60 46
3 67 47 29 1 .60 52 47by'different groups . Our results with respect to the response
or nonresponse to HBsAg are consistent with the results of
our earlier studies (16,17) and those ofMilich and coworkers
(10-14) in themouse . They are further supportedby prelimi-
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